ResearchPosted on rand.org 2007Published in: Urologic diseases in America / edited by Mark S. Litwin and Christopher S. Saigal (Washington, D.C.: US Department of Health and Human Services, Public Health, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2007), Chapter 21, p. 699-738, NIH Pub. no. 07-5512
The overall objective of the project, Urologic Diseases in America, is to quantify the burden of urologic diseases on the American public. The authors undertook this effort with the aid of sophisticated research methodologies and experienced analytic and administrative staff. Their team that included epidemiologists, health economists, statisticians, programmers, and urologists trained in health services research. The team searched all potential data sources for relevant information and health statistics in order to gather current and retrospective data on all aspects of the epidemiology, practice patterns, costs, and impact of urologic diseases in the United States. The resulting work is intended to convey meaningful information to users at various levels of medical sophistication, including the public, elected leaders, government officials, non-governmental organizations, media outlets, physicians, nurses, allied healthcare personnel, and academic researchers. Until this project, no authoritative omnibus had compiled a comprehensive set of data analyses that synthesized information available from myriad national and regional sources across the public and private sectors in the United States.
This publication is part of the RAND external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.
RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.
